Clarithromycin is a 14-member ring macrolide antibiotic and 6-O-methyl derivative of erythromycin. Clarithromycin has reported bacteriostatic action against gram-positive bacteria and some gram-negative bacteria including anaerobes. Similar to other macrolide antibiotics, this antibiotic is believed to function via binding of the ribosome within the microorganism. Studies have noted that Clarithromycin appears to bind specifically to the 50S ribosomal subunit, thus inhibiting DNA translation and inhibiting bacterial growth. This compound is both a substrate and inhibitor of CYP3A4.
1. Goldman, R.C., et al. 1994. Antimicrob. Agents Chemother. 38: 1496-1500. PMID: 7979278
2. Champney, W.S. and Miller, M. 2002. Curr. Microbiol. 44: 418-424. PMID: 12000992
3. Mamelli, L., et al. 2005. J. Antimicrob. Chemother. 56: 491-497. PMID: 16055509
4. Sadeghi-Khomami, A., et al. 2008. Chem. Biol. 15: 739-749. PMID: 18635010
See how others have used Clarithromycin (CAS 81103-11-9). Click on the entry to view the PubMed entry .
PMID: # 33552084 Ngwa, DN.|Singh, SK.|Agrawal, A.| et al. 2020. Front Immunol. 11: 620784.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.